ライフサイエンスコーパス: nuclear antigen

1 er than expression of the latency-associated nuclear antigen.

2 kinase 2 (CDK2), CDK4 and proliferating cell nuclear antigen.

3 nd the replication clamp, proliferating cell nuclear antigen.

4 ions and by immunochemical detection of Ki67 nuclear antigen.

5 ant acid phosphatase, and proliferating cell nuclear antigen.

6 t also had high levels of proliferative cell nuclear antigen.

7 ive autoantibodies directed against distinct nuclear antigens.

8 companied by production of autoantibodies to nuclear antigens.

9 The Epstein-Barr nuclear antigen 1 (EBNA-1) is an important target for va

10 Epstein-Barr nuclear antigen 1 (EBNA-1) is the only viral protein con

11 mologous proteins such as Epstein-Barr virus nuclear antigen 1 (EBNA-1) of the related gamma-herpesvi

12 associations were found between maternal EBV nuclear antigen 1 (EBNA-1), diffuse early antigen, or cy

13 Though EBV nuclear antigen 1 (EBNA1) and EBV-encoded small RNAs (EB

14 s, but also efficiently present targeted EBV nuclear antigen 1 (EBNA1) and EBV-latent membrane protei

15 The viral protein Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) binds to FR and DS to promote

16 Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is essential for EBV episome m

17 Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the EBV-encoded nuclear ant

18 dentical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that interacts with the N-term

19 IgG antibody reactivity toward ANO2 and EBV nuclear antigen 1 (EBNA1) was measured using bead-based

20 quires the interaction of Epstein-Barr virus nuclear antigen 1 (EBNA1) with the viral origin of plasm

21 Epstein-Barr Virus (EBV) Nuclear Antigen 1 (EBNA1)-mediated origin of plasmid rep

22 d nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antigen 1 (EBNA1)] necessary to maintain and rep

23 Nrf2 interacted with KSHV latency-associated nuclear antigen 1 (LANA-1) and the host transcriptional

24 in cells expressing only latency-associated nuclear antigen 1 (LANA-1) protein, and in KSHV latently

25 he expression of the KSHV latency-associated nuclear antigen 1 (LANA-1; ORF73) and LANA-1 nuclear pun

26 express nuclear antigens [latency-associated nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antig

27 ciated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) protein is constitutively expr

28 eterologous prime-boost vaccination with the nuclear antigen 1 of EBV (EBNA1), either targeted to the

29 cooperatively with EBNA1 (Epstein-Barr virus nuclear antigen 1) at OriP.

30 cargos such as STAT1 and Epstein-Barr Virus Nuclear Antigen 1, as well as the influenza virus polyme

31 nucleolus where it binds Epstein-Barr virus nuclear antigen 1-binding protein 2 (EBP2).

32 nly express the less immunogenic antigen EBV nuclear antigen-1 (EBNA-1), rendering them sensitive to

33 -LMPpoly has been generated that encodes EBV nuclear antigen-1 (EBNA1) fused to multiple CD8(+) T-cel

34 V viral capsid antigen positive Epstein-Barr nuclear antigen-1 positive serostatus at transplant (p =

35 ats (GAr) from the EBNA1 (Epstein-Barr virus nuclear antigen-1) protein, can trigger partial degradat

36 Inactivation of ESE components, EBV nuclear antigen 2 (EBNA2) and bromodomain-containing pro

37 fold enrichment in host regions bound by EBV nuclear antigen 2 (EBNA2) and EBNA3 transcription factor

38 Activated Notch and EBV nuclear antigen 2 (EBNA2) both function as transcription

39 d latent viral Cyclin and latency-associated nuclear antigen 2 levels in PEL cells.

40 hich mimics CD40 signaling), and EBV-encoded nuclear antigen 3A (EBNA3A) and EBNA3C (which inhibit on

41 Epstein-Barr virus nuclear antigen 3C (EBNA3C) repression of CDKN2A p14(ARF

42 Epstein-Barr nuclear antigen 3C (EBNA3C), one of the essential EBV la

43 Proliferating cell nuclear antigen, a DNA sliding clamp, interacts with and

44 EBV nuclear antigens also repress CDKN2A to suppress senesce

45 ence of NKT cells hepatic proliferating cell nuclear antigen and cyclin B1 decreased in mice injected

46 ntly (P < 0.05) inhibited proliferating cell nuclear antigen and cyclin D and caused considerable apo

47 ication factor C-Delta1N, proliferating cell nuclear antigen and DNA polymerase delta was found to re

48 d in the presence of both proliferating cell nuclear antigen and DNA, but the activity was not shut d

49 ation and associated with proliferating cell nuclear antigen and other components of the DNA replicat

50 Whereas association with proliferating cell nuclear antigen and participation in processive genome r

51 nuclear antigen 1 (EBNA1) is the EBV-encoded nuclear antigen and sequence-specific DNA binding protei

52 associated with increased proliferating cell nuclear antigen and tenascin-C expression.

53 ration, and expression of proliferating cell nuclear antigen and tenascin-C.

54 Proliferating cell nuclear antigen and the checkpoint clamp Rad9-Rad1-Hus1

55 We further show that proliferating cell nuclear antigen and the nucleosome compete for binding t

56 Immunostaining with proliferating cell nuclear antigen and Von Willebrand factor revealed delay

57 ly, these events promote the accumulation of nuclear antigens and activate innate sensors that drive

58 human systems, MutSalpha, proliferating cell nuclear antigen, and replication factor C activate MutLa

59 for BrdU, the mature neuron marker neuronal nuclear antigen, and the astrocytic marker glial fibrill

60 ASMC proliferation (Ki67, proliferating cell nuclear antigen, and WST1 assays) and resistance to apop

61 3-positive cells and more proliferating cell nuclear antigen- and pSMAD5-positive cells were found in

62 Amerindians and tested for HHV-8 anti-latent nuclear antigen (anti-LANA) and antilytic antibodies by

63 onegative recipients was associated with EBV nuclear antigen antibody deficiency, polymorphic disease

64 Autoantibodies to nuclear antigens arise in human autoimmune diseases, but

65 l characterization of the proliferating-cell-nuclear-antigen-associated factor p15(PAF), showing that

66 nti-double-stranded DNA and anti-extractable nuclear antigen autoantibodies following treatment with

67 leading strand, and PCNA (proliferating cell nuclear antigen) binds tightly to Pol delta and recruits

68 methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7

69 the human clamp protein, proliferating cell nuclear antigen, by monitoring the change in the fluores

70 eration was assessed with proliferating cell nuclear antigen, CD1, and Ki67 markers and along with as

71 narily interacts with the proliferating cell nuclear antigen clamp loader replication factor C, DNA p

72 Proliferating cell nuclear antigen content and signal transducer and activa

73 and protein expression of proliferating cell nuclear antigen, cyclin D1, E-cadherin, beta-catenin, Dv

74 inding protects Set8 from proliferating cell nuclear antigen-dependent degradation during the cell cy

75 es and is characterized by the production of nuclear antigen-directed autoantibodies (e.g., anti-dsDN

76 ere IgG seropositivity to Epstein-Barr virus nuclear antigen (EBNA) (random effects odds ratio [OR] 4

77 gramme, consisting of highly immunogenic EBV nuclear antigen (EBNA) and latent membrane proteins (LMP

78 ated forms of CLEC3A in HEK-293 Epstein-Barr nuclear antigen (EBNA) cells.

79 blastoid Cell Lines (LCLs) requires four EBV nuclear antigen (EBNA) oncoproteins: EBNA2, EBNALP, EBNA

80 ent for expression of the Epstein-Barr Virus nuclear antigen (EBNA), making it particularly beneficia

81 ic cells or an adenovirus approach targeting nuclear antigen EBNA1 followed by a modified vaccinia vi

82 I program, in which the single Epstein-Barr nuclear antigen (EBNA1) is produced.

83 Epstein-Barr virus (EBV) nuclear antigens EBNALP (LP) and EBNA2 (E2) are coexpres

84 EBV nuclear antigens (EBNAs) and LMP1 are EBV transcriptiona

85 EBV nuclear antigens (EBNAs) and membrane proteins constitut

86 d Cp, resulting in the expression of six EBV nuclear antigens (EBNAs) and the viral Bcl2 homologue BH

87 EBV latent membrane proteins (LMPs) and EBV nuclear antigens (EBNAs), as well as nontranslated viral

88 nt membrane proteins (LMPs) and Epstein-Barr nuclear antigens (EBNAs).

89 oxyuridine incorporation, proliferating cell nuclear antigen expression, and histone H3 phosphorylati

90 tion-PCR and detection of latency-associated nuclear antigen expression, respectively, in cell lysate

91 sured by doublecortin and proliferating cell nuclear antigen expression, was also suppressed after ne

92 to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibo

93 responsible for unloading proliferating cell nuclear antigen from newly synthesized DNA.

94 NBN1, PCNA (proliferating nuclear antigen), GADD45A (DNA damage-inducible), RAD23A

95 roportionate increases in proliferating cell nuclear antigen gene expression.

96 , EBV latent membrane protein-1 and -2A, EBV nuclear antigen, HBV-encoded X antigen, and nonstructura

97 viral genes included the latency-associated nuclear antigen homolog ORF73 but none of the regions kn

98 ences in stabilization of proliferating cell nuclear antigen in an open conformation.

99 cyclin D1, E, and A, and proliferating cell nuclear antigen in meningeal cells while significantly r

100 or mono-ubiquitination of proliferating-cell nuclear antigen in response to oxidative DNA damage, whi

101 creased expression of proliferating cellular nuclear antigen in Sertoli cells were observed in Ppard(

102 ignificantly prevented reduction of neuronal nuclear antigen in the infarcted area, although no impro

103 conclusion, lower IgG autoantibodies against nuclear antigens in DLE+SLE+ versus DLE-SLE+ subjects su

104 f a multitude of membranous, cytoplasmic and nuclear antigens in whole mouse organs and embryos, huma

105 the proliferation marker, proliferating cell nuclear antigen, indicative of intestinal injury.

106 tion that p12 possesses a proliferating cell nuclear antigen-interacting protein-degron (PIP-degron)

107 ic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting

108 ct regions, including the proliferating-cell-nuclear-antigen-interacting protein motif (PIP-box) and

109 A conserved proliferating cell nuclear antigen interaction protein box of APE2 is impor

110 ch compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instabil

111 rmal thickening, blocked the accumulation of nuclear antigen Ki67(+) cells in the basal and the supra

112 we show that KSHV-encoded latency-associated nuclear antigen (LANA) disrupts the association of CIITA

113 increased numbers of KSHV latency-associated nuclear antigen (LANA) dots, as detected by immunofluore

114 The latency-associated nuclear antigen (LANA) encoded by Kaposi's sarcoma-assoc

115 The latency-associated nuclear antigen (LANA) encoded by KSHV plays a key role

116 hown to interact with the latency-associated nuclear antigen (LANA) encoded by KSHV.

117 ls of mRNAs encoding KSHV latency-associated nuclear antigen (LANA) in primary effusion lymphoma (PEL

118 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a 1,162-amino-acid protein tha

119 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a 1,162-amino-acid protein tha

120 Latency-associated nuclear antigen (LANA) is a conserved gamma-2-herpesviru

121 Latency-associated nuclear antigen (LANA) is a conserved Rhadinovirus prote

122 Latency-associated nuclear antigen (LANA) is a conserved, multifunctional p

123 Latency-associated nuclear antigen (LANA) is a multifunctional protein enco

124 g KSHV gene products, the latency-associated nuclear antigen (LANA) is absolutely required in the mai

125 Latency-associated nuclear antigen (LANA) is central to episomal tethering,

126 Latency-associated nuclear antigen (LANA) is essential for maintaining the

127 Latency-associated nuclear antigen (LANA) is one of the major proteins expr

128 The latency-associated nuclear antigen (LANA) is required for latent replicatio

129 Latency-associated nuclear antigen (LANA) is the most abundantly expressed

130 KSHV latency-associated nuclear antigen (LANA) mediates persistence of viral epi

131 The latency-associated nuclear antigen (LANA) of Kaposi sarcoma herpesvirus (KS

132 The latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associate

133 constitutively expressed latency-associated nuclear antigen (LANA) of the virus.

134 erpesvirus (KSHV)-encoded latency-associated nuclear antigen (LANA) protein functions in latently inf

135 Using immunofluorescence labeling of latent nuclear antigen (LANA) protein, together with fluorescen

136 geted by the KSHV-encoded latency-associated nuclear antigen (LANA) to repress expression of the majo

137 aposi sarcoma herpesvirus latency-associated nuclear antigen (LANA)(1-23), human papillomavirus 8 E2,

138 Latency-associated nuclear antigen (LANA), a multifunctional protein expres

139 Latency-associated nuclear antigen (LANA), the most abundantly expressed pr

140 to the host chromosome by latency associated nuclear antigen (LANA), which binds in the terminal repe

141 t of genes, including the latency-associated nuclear antigen (LANA), which mediates viral episome per

142 , such as ORCs, MCMs, and latency-associated nuclear antigen (LANA).

143 mes are coated with viral latency-associated nuclear antigen (LANA).

144 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA).

145 teins such as herpesvirus latency-associated nuclear antigen (LANA).

146 long infections using its latency-associated nuclear antigen (LANA).

147 ion and the expression of latency-associated nuclear antigen (LANA-1) upregulates the angiogenic mult

148 on of the highly abundant latency-associated nuclear antigen, LANA, on the host genome and its impact

149 BV) are human DNA tumor viruses that express nuclear antigens [latency-associated nuclear antigen 1 (

150 The diversity of the latency protein EBV nuclear antigen leader protein (EBNA-LP) resides predomi

151 ibosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleol

152 ddress the role of MuHV-4 latency-associated nuclear antigen (mLANA) E3 ligase activity in gammaherpe

153 Here, we focused on latency-associated nuclear antigen (mLANA) encoded by murid herpesvirus-4 (

154 th induced Rad18-mediated proliferating cell nuclear antigen mono-ubiquitination during G(0), G(1) an

155 NA synthesis initiated by proliferating cell nuclear antigen monoubiquitination or less well-characte

156 Proliferating cell nuclear antigen monoubiquitination positively regulates

157 s of DNA damage, inducing proliferating cell nuclear antigen monoubiquitination, and suppressing muta

158 hrenia and 38 control subjects) for neuronal nuclear antigen (NeuN+) and 65/67 kDa isoform of glutami

159 nt reduction in levels of proliferating cell nuclear antigen, NF-kappabeta/p50, cyclooxygenase-2, and

160 polymerase sliding clamp, proliferating cell nuclear antigen or PCNA, is a ring-shaped protein comple

161 We found that fungal proliferating cell nuclear antigen-partner interaction networks diverged in

162 n, which binds DNA-loaded proliferating cell nuclear antigen (PCNA(DNA)) and recruits CRL4(Cdt2).

163 Subsequently, proliferating cell nuclear antigen (PCNA) activates MutLalpha to nick the e

164 During DNA replication, proliferating cell nuclear antigen (PCNA) adopts a ring-shaped structure to

165 Proliferating cell nuclear antigen (PCNA) and alpha-smooth muscle actin (al

166 expression of cyclins and proliferating cell nuclear antigen (PCNA) and evidence for DNA replication

167 sed platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 monoubiquitinations (s

168 Pol delta binds to proliferating cell nuclear antigen (PCNA) and functions in genome replicati

169 53 increased the level of proliferating cell nuclear antigen (PCNA) and minichromosome maintenance 4

170 red box protein 7 (Pax7), proliferating cell nuclear antigen (PCNA) and nicotinamide phosphoribosyltr

171 on factories by retaining proliferating cell nuclear antigen (PCNA) and other replisome proteins on t

172 tone substrates including proliferating cell nuclear antigen (PCNA) and promotes carcinogenesis by de

173 ctions with two proteins, Proliferating Cell Nuclear Antigen (PCNA) and Replication Protein A (RPA),

174 ication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffold protein Rev1.

175 nary complexes containing proliferating cell nuclear antigen (PCNA) and two non-classical DNA polymer

176 on factor C (RFC) and the proliferating cell nuclear antigen (PCNA) are additional components of the

177 C (RFC) and sliding clamp proliferating cell nuclear antigen (PCNA) are both essential and play criti

178 study, we identified the proliferating cell nuclear antigen (PCNA) as a nIGF-1R-binding partner.

179 hat the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates with the C-terminal do

180 and polyubiquitination of proliferating cell nuclear antigen (PCNA) by regulating the recruitment of

181 he DNA replication factor proliferating cell nuclear antigen (PCNA) can be conjugated to either the s

182 t events in the reaction: proliferating cell nuclear antigen (PCNA) clamp binding/opening/closure/rel

183 C) complex loads circular proliferating cell nuclear antigen (PCNA) clamps onto DNA where they serve

184 ubunit complex that loads proliferating cell nuclear antigen (PCNA) clamps onto primer-template DNA (

185 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) clamps using single-molecule appr

186 cle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) compared with 2- and 3-copy mice.

187 yuridine (BrdU) labeling, proliferating cell nuclear antigen (PCNA) expression and mitotic index incr

188 bp1), a key in regulating proliferating cell nuclear antigen (PCNA) expression and ribosomal RNA (rRN

189 lpha/beta, and DNA-loaded proliferating cell nuclear antigen (PCNA) for activation.

190 ough its interaction with proliferating cell nuclear antigen (PCNA) for nucleosome assembly, particip

191 Proliferating cell nuclear antigen (PCNA) forms a trimeric ring that associ

192 Proliferating cell nuclear antigen (PCNA) forms a trimeric ring that encirc

193 ATM co-precipitates with proliferating cell nuclear antigen (PCNA) from cellular extracts.

194 eling as well as Ki67 and proliferating cell nuclear antigen (PCNA) immunofluorescence, we determined

195 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) in replication factor C (RFC)-cat

196 Proliferating cell nuclear antigen (PCNA) is a critical player in cell prol

197 Proliferating cell nuclear antigen (PCNA) is a highly conserved protein nec

198 Proliferating cell nuclear antigen (PCNA) is a protein which is involved in

199 Proliferating cell nuclear antigen (PCNA) is a sliding clamp that acts as a

200 Proliferating cell nuclear antigen (PCNA) is an essential component for DNA

201 The sliding clamp proliferating cell nuclear antigen (PCNA) is an indispensable component of

202 Proliferating cell nuclear antigen (PCNA) is required for DNA homologous re

203 The sliding clamp protein proliferating cell nuclear antigen (PCNA) is situated at the core of the eu

204 Proliferating cell nuclear antigen (PCNA) lies at the center of the faithfu

205 Proliferating cell nuclear antigen (PCNA) loading by replication factor C (

206 erturbation that supports proliferating cell nuclear antigen (PCNA) loading by replication factor C,

207 se and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) trig

208 omotrimeric sliding clamp proliferating cell nuclear antigen (PCNA) mediates Okazaki fragment maturat

209 se RAD18 is necessary for proliferating cell nuclear antigen (PCNA) monoubiquitination and TLS polyme

210 7 promoted the UV-induced proliferating cell nuclear antigen (PCNA) monoubiquitination in Poleta-prof

211 FANCD2 can still support proliferation cell nuclear antigen (PCNA) monoubiquitination.

212 to damaged DNA relies on proliferating cell nuclear antigen (PCNA) monoubiquitylation and is regulat

213 ependent kinase (CDK) and proliferating cell nuclear antigen (PCNA) onto chromatin, as well as initia

214 The sliding clamp proliferating cell nuclear antigen (PCNA) plays a vital role in a number of

215 Proliferating cell nuclear antigen (PCNA) plays an important role in both m

216 wn that monoubiquitinated proliferating cell nuclear antigen (PCNA) plays an important role in recrui

217 raction between RECQ5 and proliferating cell nuclear antigen (PCNA) promotes RAD18-dependent PCNA ubi

218 Proliferating cell nuclear antigen (PCNA) recruits Pol delta to the DNA and

219 (Pol delta) bound to the proliferating cell nuclear antigen (PCNA) replicates the lagging strand and

220 mplate and anchors to the proliferating cell nuclear antigen (PCNA) sliding clamp to form a holoenzym

221 ive monoubiquitination of proliferating cell nuclear antigen (PCNA) sliding clamps encircling damaged

222 d arteries as assessed by proliferating cell nuclear antigen (PCNA) staining was also higher.

223 evels of doublecortin and Proliferating Cell Nuclear Antigen (PCNA) suggested increased neurogenesis.

224 of the DNA clamp protein proliferating cell nuclear antigen (PCNA) to DNA lesions.

225 ainst an oncology target, proliferating cell nuclear antigen (PCNA) to elicit rapid and robust PCNA d

226 DNA damage-induced proliferating cell nuclear antigen (PCNA) ubiquitination serves as the key

227 KT-mediated modulation of Proliferating Cell Nuclear Antigen (PCNA) ubiquitylation after UV requires

228 titutively interacts with proliferating cell nuclear antigen (PCNA) via a highly conserved PIP box mo

229 brain mantle and express proliferating cell nuclear antigen (PCNA), a cell cycling marker, indicate

230 ymerase alpha holoenzyme, proliferating cell nuclear antigen (PCNA), a homotrimeric DNA sliding clamp

231 RV2) and the host-encoded proliferating cell nuclear antigen (PCNA), a key DNA replication protein in

232 ow that monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA), a marker of stalled replication

233 cently described that the proliferating cell nuclear antigen (PCNA), a nuclear factor involved in DNA

234 previously described that proliferating cell nuclear antigen (PCNA), a nuclear scaffolding protein pi

235 Proliferating cell nuclear antigen (PCNA), a potential anticancer target, f

236 that described for human proliferating cell nuclear antigen (PCNA), a small ubiquitin-like modifier

237 acidophilum interact with proliferating cell nuclear antigen (PCNA), an essential co-factor for DNA p

238 the recruitment of Cdc45, proliferating cell nuclear antigen (PCNA), and polymerase delta, but not OR

239 y stabilization of Mcl-1, proliferating cell nuclear antigen (PCNA), and pro-caspase-3.

240 Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replication factor C (RFC) a

241 Proliferating cell nuclear antigen (PCNA), bone sialoprotein (BSP), osteoca

242 complex monoubiquitinates proliferating cell nuclear antigen (PCNA), but the basis for recruitment of

243 age and monoubiquitinates proliferating cell nuclear antigen (PCNA), facilitating engagement of Polet

244 nding capability of human proliferating cell nuclear antigen (PCNA), identified the lysine residue in

245 ability to interact with proliferating cell nuclear antigen (PCNA), it enhances its interaction with

246 ith the replication clamp proliferating cell nuclear antigen (PCNA), respectively.

247 s, Poliota interacts with proliferating cell nuclear antigen (PCNA), Rev1, ubiquitin and ubiquitinate

248 Increased expression of proliferating cell nuclear antigen (PCNA), TGF-beta, and p-AKT and decrease

249 the proliferation marker proliferating cell nuclear antigen (PCNA), the anti-inflammatory cytokine i

250 1 inhibits recruitment of proliferating cell nuclear antigen (PCNA), the platform for assembly of the

251 Proliferating cell nuclear antigen (PCNA), the processivity factor for DNA

252 mbly might be governed by proliferating cell nuclear antigen (PCNA), the processivity factor of repli

253 The expression levels of proliferating cell nuclear antigen (PCNA), vascular endothelial growth fact

254 Lack of SIM, but not proliferating cell nuclear antigen (PCNA)-interacting motif (PIM), leads to

255 tic figures, and BrdU and proliferating cell nuclear antigen (PCNA)-reactive cells showed that, in co

256 Enok complex and the Elg1 proliferating cell nuclear antigen (PCNA)-unloader complex.

257 ance the transcription of proliferating cell nuclear antigen (PCNA).

258 d by its interaction with proliferating cell nuclear antigen (PCNA).

259 e interaction of TDG with proliferating cell nuclear antigen (PCNA).

260 equence alteration of the proliferating cell nuclear antigen (PCNA).

261 y their interactions with proliferating cell nuclear antigen (PCNA).

262 ractions between TXR1 and proliferating cell nuclear antigen (PCNA).

263 lisome through binding to proliferating cell nuclear antigen (PCNA).

264 ith the replication clamp proliferating cell nuclear antigen (PCNA).

265 h the processivity factor proliferating cell nuclear antigen (PCNA).

266 romatin engagement of the proliferating cell nuclear antigen (PCNA).

267 g-shaped homotrimeric proliferating cellular nuclear antigen (PCNA).

268 n of Nox4, TNF-alpha, and proliferating cell nuclear antigen (PCNA).

269 ll molecule inhibitors of proliferating cell nuclear antigen (PCNA)/PCNA interacting protein box (PIP

270 ocessivity clamps such as proliferating cell nuclear antigen (PCNA); however, the exact mechanism of

271 e heterotrimeric PCNA123 [proliferating cell nuclear antigen (PCNA)] clamp onto DNA that includes a r

272 replication foci and the proliferating cell nuclear antigen(PCNA) protein have a high level of proxi

273 e-positive cells and more proliferating cell nuclear antigen-positive cells in all treatment groups r

274 lso showed an increase in proliferating cell nuclear antigen-positive renal tubules.

275 (P < 0.05) the number of proliferating cell nuclear antigen-positive tubular epithelial cells at 24

276 raction between XEco2 and proliferating cell nuclear antigen prevents cohesion establishment while ha

277 report an ancient family of GCNA (germ cell nuclear antigen) proteins that arose in the earliest euk

278 on polyubiquitylation of proliferating cell nuclear antigen provides a backup mechanism for accurate

279 e observations show that fecal IgA features, nuclear antigen reactivity particularly, at preclinical

280 tive DNA polymerase delta/proliferating cell nuclear antigen/replication factor C complex on telomeri

281 ell cycle (e.g. P. patens proliferating cell nuclear antigen, ribonucleotide reductase, and minichrom

282 lation of chromatin-bound proliferating cell nuclear antigen, slowed cell division, and increased gen

283 EBNA1 is the EBV-encoded nuclear antigen that is consistently expressed in all EB

284 ial for cccDNA formation: proliferating cell nuclear antigen, the replication factor C complex, DNA p

285 replication factor C and proliferating cell nuclear antigen to perform efficient DNA synthesis in vi

286 stimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase assays; and gene exp

287 tions and perform IHC for proliferating cell nuclear antigen, upstream binding factor, RNA polymerase

288 , HDAC1, and HDAC2) together with EBV latent nuclear antigens using next-generation sequencing (NGS)

289 n by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18 and UBC13-MMS2-RAD

290 estasis, but unexpectedly proliferating cell nuclear antigen was down-regulated at 12 days after chol

291 LR assessed by Ki-67 and proliferating cell nuclear antigen was markedly decreased in Itpr2(-/-) mic

292 lls harboring fluorescent proliferating cell nuclear antigen, we confirmed that 8a significantly and

293 ce, whereas cyclin D1 and proliferating cell nuclear antigen were decreased to reduce cell proliferat

294 ant acid phosphatase, and proliferating cell nuclear antigen were evaluated by histochemical and immu

295 of hepatic cyclin B1 and proliferating cell nuclear antigen were evaluated by Western Blot and liver

296 Ki-67 and proliferating cell nuclear antigen were used to measure hepatocytes prolife

297 cated by co-staining with proliferating cell nuclear antigen, whereas Notch3 was expressed throughout

298 NANCE 2-7 gene family and PROLIFERATING CELL NUCLEAR ANTIGEN, which encode essential DNA replication

299 Nuclear antigens, which activate dendritic cells (DCs),

300 ractions of S. cerevisiae Proliferating Cell Nuclear Antigen (yPCNA) with modified DNA sequences and